Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VERV holding history

Verve Therapeutics, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VERV overview All 13F holders of VERV Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of VERV by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−29,200−100.0%	Sold out	Holders
Q1 2024	29,200	$387.8K	<0.1%	−9,800−25.1%	Reduced	Holders
Q4 2023	39,000	$543.7K	<0.1%	+39,000	New	Holders